Table 1.
Clinical information of train and validation datasets in TCGA_UVM cohort and HX cohort. IQR means interquartile range
| Datasets | ||||||
|---|---|---|---|---|---|---|
| level | train | validation | HX cohort | p | test | |
| n | 56 | 24 | 67 | |||
| futime (median [IQR]) | 759.50 [466.25, 1159.75] | 816.00 [352.00, 1290.25] | 1590.00 [555.00, 2280.00] | 1.93E-04 | Kruskal–Wallis Test | |
| fustat (median [IQR]) | 0.00 [0.00, 1.00] | 0.00 [0.00, 1.00] | 0.00 [0.00, 0.00] | 9.57E-01 | Kruskal–Wallis Test | |
| age (median [IQR]) | 60.00 [49.75, 74.00] | 64.00 [54.00, 76.00] | 52.00 [41.00, 59.00] | 2.89E-05 | Kruskal–Wallis Test | |
| gender (%) | female | 24 (42.9) | 11 (45.8) | 31 (46.3) | 9.26E-01 | Chisq Test |
| male | 32 (57.1) | 13 (54.2) | 36 (53.7) | |||
| stage (%) | Stage II | 26 (46.4) | 10 (41.7) | — | 3.21E-01 | Chisq Test |
| Stage III | 26 (46.4) | 14 (58.3) | — | |||
| Stage IV | 4 (7.1) | 0 (0.0) | — | |||
| histological_type (%) | epithelioid | 9 (16.1) | 4 (16.7) | 25 (37.3) | 5.48E-03 | Chisq Test |
| mixed | 27 (48.2) | 10 (41.7) | 13 (19.4) | |||
| spindle | 20 (35.7) | 10 (41.7) | 29 (43.3) | |||
| chromosome.3.status (%) | disomy | 25 (44.6) | 13 (54.2) | — | 5.91E-01 | Chisq Test |
| monosomy | 31 (55.4) | 11 (45.8) | — | |||
| MetStatus (%) | Metastatic | 20 (35.7) | 6 (25.0) | 18 (26.9) | 4.79E-01 | Chisq Test |
| Non-metastatic | 36 (64.3) | 18 (75.0) | 49 (73.1) | |||
| vital_status (%) | alive | 40 (71.4) | 17 (70.8) | 51 (76.1) | 8.00E-01 | Chisq Test |
| dead | 16 (28.6) | 7 (29.2) | 16 (23.9) | |||
| SCNA_Cluster (%) | A | 8 (14.3) | 7 (29.2) | — | 2.78E-01 | Chisq Test |
| B | 17 (30.4) | 6 (25.0) | — | |||
| C | 18 (32.1) | 4 (16.7) | — | |||
| D | 13 (23.2) | 7 (29.2) | — | |||